Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough

NCT03282591 is registered in ClinicalTrials.gov with Vyne Therapeutics Inc. as lead sponsor.

NCT NCT03282591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03282591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Lead sponsor
Vyne Therapeutics Inc.
Phase
Phase 2
Overall status
Completed
Start date
October 3, 2017
Completion date
September 6, 2018
Enrollment
185 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

refractory chronic cough